英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
presaging查看　presaging　在百度字典中的解释百度英翻中〔查看〕
presaging查看　presaging　在Google字典中的解释Google英翻中〔查看〕
presaging查看　presaging　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Homepage - RAPT Therapeutics
    RAPT Therapeutics is a clinical-stage biopharmaceutical company driven by our mission to treat inflammatory and immunologic diseases Our cutting-edge science is fully focused on developing therapeutics that intelligently target key drivers of the immune system to transform the treatment of inflammatory and immunologic diseases, and improve and empower countless lives Join us in our quest
  • RAPT Therapeutics Reports Third Quarter 2025 Financial Results and . . .
    - Initiated prestIgE Phase 2b trial of ozureprubart in food allergy - Announced positive topline data from Phase 2 trial in chronic spontaneous urticaria; results showed ozureprubart at both Q8W and Q12W dosing had comparable efficacy and safety to omalizumab at Q4W dosing - Completed $250 million
  • RAPT Therapeutics Announces FDA Clearance of IND Application to Proceed . . .
    RAPT on track to initiate trial this year SOUTH SAN FRANCISCO, Calif , Sept 29, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living
  • GSK enters agreement to acquire RAPT Therapeutics - RAPT Therapeutics
    GSK has acquired RAPT Therapeutics Further information can be found in the latest press release
  • RAPT Therapeutics Announces $150 Million Private Placement - RAPT . . .
    SOUTH SAN FRANCISCO, Calif , Dec 23, 2024 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developing and commercializing novel therapies for patients with significant unmet needs in inflammatory diseases,
  • RAPT Therapeutics Reports Fourth Quarter and Full Year 2024 Financial . . .
    SOUTH SAN FRANCISCO, Calif , March 06, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc (Nasdaq: RAPT) (“RAPT” or the “Company”) is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with
  • RAPT Therapeutics Initiates prestIgE Phase 2b Clinical Trial of . . .
    Trial initiation in food allergy follows promising results in Phase 2 trial in chronic spontaneous urticaria, another IgE-driven condition RAPT seeks to develop a differentiated anti-IgE therapy for the many patients with food allergies SOUTH SAN FRANCISCO, Calif , Oct
  • RAPT Therapeutics Expands Leadership Team with Multiple Key Hires . . .
    SOUTH SAN FRANCISCO, Calif , May 04, 2022 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in
  • RAPT Therapeutics Announces Effective Date for 1-for-8 Reverse Stock . . .
    SOUTH SAN FRANCISCO, Calif , June 13, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc (Nasdaq: RAPT) (the “Company”), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and
  • RAPT Therapeutics Announces Proposed Public Offering of Common Stock . . .
    SOUTH SAN FRANCISCO, Calif , Oct 21, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc (Nasdaq: RAPT) (“RAPT”), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological





中文字典-英文字典  2005-2009